GNRX
VanEck Vectors Generic Drugs ETF
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Indxx Global Generics & New Pharma Index. The index includes exchange-listed companies, on a global basis, that derive a significant proportion of their revenues (or that have the potential to derive a significant proportion of their revenues) from the generic drug industry, or that have a primary business focus on the generic drug industry. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. It is non-diversified.
Market Cap: 3.95 Million
Primary Exchange: NASDAQ Global Market
Website: http://www.marketvectorsetfs.com
Shares Outstanding: 150 Thousand
Float: 150 Thousand
Dividend: 0.367 (1.39%)
Beta: 1.270546
Sector:
Industry:
Ethical Flags
Longest drawdown: 1006 trading days
From: 2018-01-12 To: 2019-04-05
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|